96 related articles for article (PubMed ID: 7762743)
21. [Diagnosis of the heterozygote carrier state in 21-hydroxylase deficiency using steroids].
Sulcová J; Hampl R; Foretová L; Vána V; Stárka L
Vnitr Lek; 1990 Jul; 36(7):643-8. PubMed ID: 2174197
[TBL] [Abstract][Full Text] [Related]
22. Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers of 21-hydroxylase deficiency.
Napolitano E; Manieri C; Restivo F; Composto E; Lanfranco F; Repici M; Pasini B; Einaudi S; Menegatti E
J Endocrinol Invest; 2011; 34(7):498-501. PubMed ID: 20671415
[TBL] [Abstract][Full Text] [Related]
23. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency.
Levine LS; Dupont B; Lorenzen F; Pang S; Pollack M; Oberfield SE; Kohn B; Lerner A; Cacciari E; Mantero F; Cassio A; Scaroni C; Chiumello G; Rondanini GF; Gargantini L; Giovannelli G; Virdis R; Bartolotta E; Migliori C; Pintor C; Tato L; Barboni F; New MI
J Clin Endocrinol Metab; 1981 Dec; 53(6):1193-8. PubMed ID: 6271801
[TBL] [Abstract][Full Text] [Related]
24. [Clinical polymorphism of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency and HLA phenotype].
Dzenis IG; Brykova EK; Bakharev VA
Akush Ginekol (Mosk); 1990 Jan; (1):10-4. PubMed ID: 2353725
[No Abstract] [Full Text] [Related]
25. Novel human pathological mutations. Gene Symbol: CYP21A2. Disease: Non-classic 21-hydroxylase deficiency.
Concolino P; Santonocito C; Minucci A; Carrozza C; Zuppi C; Capoluongo E; Giardina B
Hum Genet; 2007 Dec; 122(5):559. PubMed ID: 18386334
[No Abstract] [Full Text] [Related]
26. [Genetic of the 21 hydroxylase deficiency].
Boué A; Couillin P; Pomarède R; Rappaport R; Boué J
Ann Endocrinol (Paris); 1982; 43(1):3-14. PubMed ID: 6982657
[TBL] [Abstract][Full Text] [Related]
27. [Gene defects in congenital adrenal hyperplasia in Finnish patients].
Partanen J; Narko K
Duodecim; 1993; 109(6):512-7. PubMed ID: 8062719
[No Abstract] [Full Text] [Related]
28. Prenatal diagnosis of a heterozygote of salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency by genetic linkage analysis.
Oh BH; Park JK; Choi YM; Yang IM; Kim YS; Choi YK
J Korean Med Sci; 1988 Jun; 3(2):73-7. PubMed ID: 3267357
[TBL] [Abstract][Full Text] [Related]
29. A steroid 21-hydroxylase allele concomitantly carrying four disease-causing mutations is not uncommon in the swedish population.
Wedell A; Chun X; Luthman H
Hum Genet; 1994 Feb; 93(2):204-6. PubMed ID: 8112748
[TBL] [Abstract][Full Text] [Related]
30. The attenuated form of congenital adrenal hyperplasia as an allelic form of 21-hydroxylase deficiency.
Migeon CJ; Rosenwaks Z; Lee PA; Urban MD; Bias WB
J Clin Endocrinol Metab; 1980 Sep; 51(3):647-9. PubMed ID: 6251108
[TBL] [Abstract][Full Text] [Related]
31. How can molecular biology contribute to the management of congenital adrenal hyperplasia?
Ritzén EM; Lajic S; Wedell A
Horm Res; 2000; 53 Suppl 1():34-7. PubMed ID: 10895040
[TBL] [Abstract][Full Text] [Related]
32. Unexplained infertility: increased risk for 21-hydroxylase-deficiency in parents and offspring?
Baumgartner-Parzer S; Vytiska-Binsdorfer E; Kleinle S; Heinze G; Vierhapper H
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():258-9. PubMed ID: 25306100
[No Abstract] [Full Text] [Related]
33. Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.
Pardini DP; Kater CE; Vieira JG; Biglieri EG
J Clin Endocrinol Metab; 1983 Nov; 57(5):1061-6. PubMed ID: 6311859
[TBL] [Abstract][Full Text] [Related]
34. Mutations in steroid 21-hydroxylase (CYP21).
White PC; Tusie-Luna MT; New MI; Speiser PW
Hum Mutat; 1994; 3(4):373-8. PubMed ID: 8081391
[TBL] [Abstract][Full Text] [Related]
35. Nonsense mutation causing steroid 21-hydroxylase deficiency.
Globerman H; Amor M; Parker KL; New MI; White PC
J Clin Invest; 1988 Jul; 82(1):139-44. PubMed ID: 3267225
[TBL] [Abstract][Full Text] [Related]
36. Multiple tumors associated with late-onset congenital adrenal hyperplasia due to aberrant splicing of adrenal 21-hydroxylase gene.
Boos CJ; Rumsby G; Matfin G
Endocr Pract; 2002; 8(6):470-3. PubMed ID: 15251833
[No Abstract] [Full Text] [Related]
37. Genotype of classic congenital adrenal hyperplasia and the 60-minute adrenocorticotropic hormone stimulation test.
Tsai WY; Lee JS; Hsiao PH; Hsieh RP
J Formos Med Assoc; 1995; 94(1-2):10-3. PubMed ID: 7613227
[TBL] [Abstract][Full Text] [Related]
38. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.
New MI; Lorenzen F; Lerner AJ; Kohn B; Oberfield SE; Pollack MS; Dupont B; Stoner E; Levy DJ; Pang S; Levine LS
J Clin Endocrinol Metab; 1983 Aug; 57(2):320-6. PubMed ID: 6306039
[TBL] [Abstract][Full Text] [Related]
39. Zona fasciculata 21-hydroxysteroids and precursor-to-product ratios in 21-hydroxylase deficiency: further characterization of classic and non-classic patients and heterozygote carriers.
Costa-Barbosa FA; Carvalho VM; Nakamura OH; Bachega TA; Vieira JG; Kater CE
J Endocrinol Invest; 2011 Sep; 34(8):587-92. PubMed ID: 20924223
[TBL] [Abstract][Full Text] [Related]
40. Successful pregnancy in a woman with rare compound heterozygoticity for congenital adrenal hyperplasia; case report.
Kontoleon P; Ilias I; Papapetrou PD
Clin Exp Obstet Gynecol; 2003; 30(4):263-4. PubMed ID: 14664429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
